Tumor Associated Hyperinsulinism clinical trials

Explore recruiting tumor associated hyperinsulinism clinical trials.

Recruiting tumor associated hyperinsulinism studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tumor Associated Hyperinsulinism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Single-Arm, Open-label, Pivotal Study to Evaluate the Efficacy and Safety of Ersodetug Compared to Baseline in Patients with Inadequately Controlled Hypoglycemia Due to Tumor-Associated Hyperinsulinism (Tumor HI)

France, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Tumor Associated Hyperinsulinism trials by city

Tumor Associated Hyperinsulinism in Toronto Tumor Associated Hyperinsulinism in Vancouver Tumor Associated Hyperinsulinism in Montreal Tumor Associated Hyperinsulinism in Calgary Tumor Associated Hyperinsulinism in Edmonton Tumor Associated Hyperinsulinism in Ottawa Tumor Associated Hyperinsulinism in Winnipeg Tumor Associated Hyperinsulinism in Quebec City Tumor Associated Hyperinsulinism in Hamilton Tumor Associated Hyperinsulinism in Kitchener Tumor Associated Hyperinsulinism in London Tumor Associated Hyperinsulinism in Halifax Tumor Associated Hyperinsulinism in New York Tumor Associated Hyperinsulinism in Los Angeles Tumor Associated Hyperinsulinism in Chicago Tumor Associated Hyperinsulinism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease